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INTRODUCTION 
Βeta thalassemia major is the most widespread 
autosomal recessive hereditary disease [1].  This disease 
is characterized by the decreased synthesis of beta 
polypeptide chains [2]. Thalassemia is usually 
associated with many complications such as 
atherosclerosis, severe infections, pallor, 
hepatosplenomegaly, gall stones, and some bone 
deformities that alter facial structures. The overall effect 
of all these characteristics leads to pathological changes 
like ineffective erythropoiesis, jaundice, hemolysis, 
which further lead s severe anemia [3,4]. 
Beta thalassemia is treated with multiple blood 
transfusions, which mainly leads to the iron overload 
and generation of oxidative stress [4]. Today, different 
studies indicate that the high levels of oxygen together 
with hemoglobin containing iron attacks on the non-
saturated fatty acids and RBCs, results in excess 
production of (OH), singlet oxygen, and reactive 
oxygen species (ROS) in the red blood cells of 
thalassemia patients, this alters the redox status of these 
patients and intensification of oxidative stress with 
gross depletion of antioxidant nutrients [4,5]. 
Correspondence: : Dr. S. S. Ghodake, Prof & Head, Department of Biochemistry, DVVPF’s Medical College,       
Ahmednagar, Maharashtra, India. Email: ghodke3@gmail.com  
In India, every year, more than 10,000 children are born 
with thalassemia major. About 190 million throughout 
the world having genetic mutations associated with 
different hemoglobinopathies, and more than 90 million 
of them carry defective genes leading to thalassemia [6-
8].  
The trace elements and minerals play a crucial role in 
the body to perform overall functions properly [9].  
Zinc has a vital role in red blood cell survival, and zinc 
deficiency leads to membrane fragility 10. Copper is the 
measure component of hemoglobin, and it is the central 
component of the antioxidant superoxide dismutase 
molecule. It also helps in the formation of a protein 
called ceruloplasmin, which protects the cells from free 
radical injury [9]. Zinc was a deficient and enhanced 
copper concentration in major thalassemia patients. The 
zinc level mainly decreased due to attributable to iron 
chelation, dietary deficiency, increased urinary zinc 
excretion, chronic infections, and ongoing hemolysis. 
The copper is increased mainly due to a compensatory 
mechanism and due to hemochromatosis [9, 10]. 
Supplementation with zinc orally (50mg/day) in beta-
thalassemia major patients leads to enhance trace 
elements concentration and boosts the overall immune 
response11. Due to regular blood transfusion, there was 
enhanced oxidative stress due to secondary iron 
overload along with depleted levels of trace elements in 
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thalassemia major. Due to additional supplementation of 
zinc decreases the hemolysis, maintains cell integrity, 
and inhibit the oxidative stress [11,12]. 
MATERIAL AND METHODOLOGY    
Study design: The study is a randomized, single-
blinded placebo-controlled prospective study. 
Ethics approval: The Institutional Ethical Committee 
clearance was obtained from the above mentioned 
institutes, and the utmost care was taken during study 
procedure according to the Declaration of Helsinki 
1975.    
Study locus: This research was conducted in the 
Department of Biochemistry PDVVPF’s Medical 
College, Ahmednagar, Maharashtra.  
Study time frame: The duration of the study was 15 
months.  
Sample size: The study has been performed on a total of 
104 subjects 
Inclusion criteria: Which included 52 age and sex-
matched (28 males and 24 females) healthy normal and 
52 (17 males and 35 females) β- thalassemia children, 
which were previously diagnosed by High-Performance 
Liquid Chromatography (HPLC) and electrophoretic 
patterns. All thalassemic patients receive an oral dose of 
deferiprone as an iron chelator in a regular dose. All 
patients were under the strict supervision of medical 
professionals during this period. The patients were 
blood transfusion-dependent, aged between 4-10 years. 
The average hemoglobin concentration ranged between 
3 -7.7 gm/dl. 
Exclusion criteria: All the patients having a history of 
hypertension, thyroid dysfunction, diabetes mellitus, 
cardiovascular diseases, which induce oxidative stress, 
were excluded from the study.  
Grouping: Group 1 Healthy volunteers ( Control), 
group 2: beta-thalassemia major children 
Methodology 
A total of 3ml blood was withdrawn aseptically from 
the antecubital vein from each subject in plain blub. The 
samples were centrifuged at 3000 rpm for 10 min to 
separate serum. The separated serum was collected in a 
polythene tube with cork and stored at -200C. The serum 
with no sign of hemolysis was used for the analysis of 
all the parameters. Serum zinc and copper was assessed 
by atomic absorption spectrophotometry [13].The 
assessment of the above parameters from patient groups 
was conducted before and after 6 months of the zinc 
supplementation 50mg/day orally O.D.  
Statistical analysis: The statistical analysis was carried 
out by using the SPSS (Statistical Package for Social 
Sciences) software, version 16.0 for Windows. The 
Student ‘Z’ test was applied to assess the difference 
between means of intervention and normal and pre and 
post-intervention data. The results were expressed in 
mean ± SD; p values (p <0.001) were considered as 
highly significant, and p values (p >0.05) were 
considered as non-significant. 
RESULTS  
Table-1 shows significantly decreased (p<0.001) levels of 
serum zinc and the level of copper was increased 
significantly (p<0.001) in patients with beta-thalassemia 
major when compared with healthy normal before 
supplementation. After six months of zinc 
supplementation to patients group along with regular 
treatment, it was observed that a significant increase in 
the levels of zinc (p<0.001) and a non-significant increase 
in serum copper concentration (p >0.05)was seen when 
compared with baseline results.  
Table 1: Serum zinc and copper concentrations in 
normal and beta-thalassemia major children before 
and after zinc supplementation 
Values are expressed in mean with standard deviation 
(mean ± SD). Statistical comparison was done between 
normal, group II before and after by applying student ‘Z’ 
test for individual comparison. **P <0.001- considered as 
highly significant. **comparison between group 1 and 
Group II before supplementation of zinc, $$ Comparison 
between group before and after supplementation of Zinc  
DISCUSSION 
Zinc is an essential element for growth and immunity10. 
Due to regular blood transfusion, there was a continuous 
iron overload, which leads to enhanced oxidative stress 
and diminished antioxidant concentrations [14]. Our 
findings suggest that iron overload may be the most 
substantial negative influence on circulating 
micronutrients such as zinc, vitamin E, C, and overall 
antioxidant status [15]. 
Our findings confirm with Mohammadreza Rashidi et al. 
that they found the significantly lowered activity of serum 
zinc in patients with beta-thalassemia major. With 
research, they proved that supplementation of oral zinc 
with vitamin E increases the serum zinc and vitamin E 
concentration [16]. This helps to reduce the hemolytic 
rate and thereby decreases the urinary excretion of zinc in 
major thalassemia patients. 
Excess iron accumulation leads to growth impairment, 
endocrinopathy, hypogonadism, etc. in beta-thalassemia 
patients. Various reports emphasize the role of zinc and 
copper associated with these clinical problems. Zinc is the 
essential nutrient and is considered to be an essential 
mineral preceded by iron.  
Abolfazl et al. described depletion in zinc activity and 
elevated copper level in patients with β-thalassemia 
major. He further explained that the cause of zinc 
deficiency was due to insufficient dietary zinc intake, and 
hence he recommended additional zinc supplementation 
for thalassemia patients [17]. 
Our findings sustained with the results made by Ghone 
RA et al. that depleted serum zinc in β-thalassemia major 
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(n=52) 
Before After 
Serum zinc 97.34± 81.19 62.87±07.1** 75.3±05.8
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Serum copper 138.58± 14.9 138.8±10.5** 142.2±10.3 
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be due to cirrhotic changes owing to hemosiderosis or it 
may be an increased rate of glomerular filtration of zinc 
as seen in chronic hemolysis. Increased copper activity 
may be due to antagonistic effects of the zinc, as a zinc 
deficiency in β-thalassemia major patients could much 
promote popper absorption via GIT [18]. 
Other researchers also provided similar reports. They 
attributed that the cause of hypozincemia in thalassemia 
major is hyper-zincuria, which is resulted in hemolysis 
of RBCs. Some studies show that increased copper level 
may be due to hemochromatosis, which is the principal 
complication in thalassemia major [19,20]. 
CONCLUSION 
The core of the present study lies in the fact that zinc 
deficiency and tissue damage due to iron overload-
induced oxidative stress. Biologically zinc interacts with 
iron and inhibits oxidation-reduction reactions. The β-
thalassemia major patients are under the heavy risk of 
cardiovascular decreases due to increased low-density 
lipoprotein levels and deposition of free iron in the 
heart. The daily supplementation of 220 mg zinc sulfate 
capsule contented 50 mg elemental zinc for six months 
significantly improves the serum zinc level, and delays 
the cardiovascular disease risk in β-thalassemia major 
patients. 
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